Our recent Freedom of Information request to the NHS showed access to the latest diagnostic scans before a biopsy was worse in Wales than the other home nations. Find out why, what we're doing about it and how you can help.
When Raymond Starr was diagnosed with prostate cancer last year, he was refused an mpMRI on the NHS because there are no scanners available in North Wales. He's now working with us to make sure the revolutionary diagnostic technique is available to all men in the UK.
BLOG: Abiraterone should continue to be available on the NHS and opened up to all men with newly diagnosed advanced prostated cancer, argues our policy manager Tim Windle, as the UK’s drug guidelines body is set to rule on the future of the treatment.
BLOG: After Theresa May’s announcement of £75 million for prostate cancer research, Ian le Guillou looks at how government and charity funding work together and how your support is critical to bag the big bucks needed for major breakthroughs.
The Prime Minister is making the biggest prostate cancer funding announcement we have seen – a move we hope will make a significant contribution to our bid to stop prostate cancer taking lives.
This week the PSA test is in the media spotlight after results from a large prostate cancer trial were released. So what should men do if they are worried about prostate cancer? Who should have a PSA test? Our Specialist Nurse, Ali Rooke sets out the facts.
This weekend, national media picked up a story that we reported in November about an NHS England scheme trialling a “one-stop-shop” process for diagnosing prostate cancer. The story was picked up from The Daily Mail, who have recently begun a prostate cancer campaign after being moved by our news that prostate cancer is now the third biggest cancer killer.
After we investigated complaints from men unable to get hold of the off-patent prostate cancer drug, bicalutamide, the British Generic Manufacturers' Association has told us problems with supply shouldn't last long.
BLOG: BLOG: When a successful clinical trial of a new treatment is reported, what happens next? Even the most exciting new methods still have a long way to go before doctors can prescribe them. Behind the scenes, we work to try and make sure these treatments get to the men who need them. This month, Policy Manager, Tim Windle, is in the thick of it in a bid to get a combination therapy for advanced disease approved.
Results of a report released today have shown that the average time it takes for a man to receive a diagnosis of prostate cancer in England is 56 days following referral – far longer than the 28 day target that health officials are working towards and the average 14 day diagnosis period for breast cancer. We look into the reasons behind this dramatic difference and what is being done about it.